IP Library Granted Patent US 8,061,353
Granted Patent B2
US 8,061,353 · App. 11/684,370 · Granted Nov 22, 2011

Method and apparatus for delivering a dose of a gaseous drug to a patient

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,061,353
App. No.
11/684,370
Granted
Nov 22, 2011
Kind
B2
Abstract

A method and device that can vary the dose of a gaseous drug provided to a patient based on a comparison of the normal resting breath rate for each individual patient and the current breath rate of the patient so that the patient does not become desaturated.

Claims (59)

1. A method for providing a dose of a gaseous drug to a patient that has a respiratory disorder comprising:

(a) determining a normal resting breath rate for the patient; with a control circuit including a vacuum sensor, a microprocessor and an internal clock, by:

(i) sensing transitions between patient inhalations and exhalations,

(ii) monitoring and tracking the transitions,

(iii) calculating a current breath rate of the patient,

(iv) monitoring the current breath rate and determining a filtered normal resting rate specific to the patient by excluding her breath rates, and

(v) calculating a new normal resting breath rate by combining the current normal resting breath rate and the current breath rate with an algorithm and weighting them respectively to provide a new normal resting breath rate;

(b) comparing the current breath rate with the normal resting breath rate; and

(c) providing a dose of the gaseous drug based on the comparison of the current breath rate with the normal breath rate.

2. The method as recited in claim 1 wherein the dose is delivered during a first two-thirds of an inhalation cycle.

3. The method as recited in claim 1 including:

(a) determining a standard ratio of inhalation time to exhalation time during a breath for a patient;

(b) monitoring the current ratio of inhalation time to exhalation time;

(c) comparing the current ratio with the standard ratio; and

(d) adjusting the dose of the gaseous drug provided based on a change in the ratio of inhalation and exhalation.

4. The method as recited in claim 1 including varying the flow of the dose delivered to the patient so that less flow will be used when the patient is close to normal resting breath rate.

5. The method as recited in claim 1 wherein the dose is provided by the control circuit adjusting a valve to deliver an appropriate dose to the patient.

6. The method as recited in claim 1 wherein the dose is provided by the control circuit choosing from a low flow valve, a high flow valve, or a combination of the low flow and high flow valve to deliver an appropriate dose to the patient.

7. A method for providing a dose of a gaseous drug to a patient that has a respiratory disorder comprising:

(a) determining a standard ratio of inhalation time to exhalation time during a breath for the patient with a control circuit including a vacuum sensor, a microprocessor and an internal clock,

(i) sensing transitions between patient inhalations and exhalations,

(ii) monitoring and tracking the transitions,

(iii) calculating the current ratio of inhalation time to exhalation time for the patient,

(iv) monitoring the current ratio of inhalation time to exhalation time and determining a filtered normal standard ratio of inhalation time to exhalation time specific to the patient,

(v) calculating a new standard ratio of inhalation time to exhalation time by combining the current standard ratio of inhalation time to exhalation time and the current ratio of inhalation time to exhalation time with an algorithm and weighting them respectively to provide a new standard ratio of inhalation time to exhalation time;

(b) comparing the current ratio of inhalation time to exhalation time with the standard ratio of inhalation time to exhalation time; and

(c) providing the dose of the gaseous drug based on the comparison of the current ratio of inhalation time to exhalation time with the standard ratio of inhalation time to exhalation time.

8. The method as recited in claim 7 wherein the dose is delivered during a first two-thirds of an inhalation cycle.

9. The method as recited in claim 7 including varying the flow of the dose delivered to the patient so that less flow will be used when the patient is close to the standard ratio of inhalation time to exhalation time.

10. The method as recited in claim 7 wherein the dose is provided by the control circuit adjusting a valve to deliver an appropriate dose to the patient.

11. The method as recited in claim 7 wherein the dose is provided by the control circuit choosing from a low flow valve, a high flow valve, a combination of the low flow and high flow valves or a continuous flow switch to deliver an appropriate dose to the patient.

12. A method for providing a dose of a gaseous drug to a patient that has a respiratory disorder comprising:

(a) determining a resting inhalation window; for the patient with a control circuit including a vacuum sensor, a microprocessor and an internal clock, by:

(i) sensing transitions between patient inhalations and exhalations,

(ii) monitoring and tracking the transitions,

(iii) calculating a current inhalation window for the patient,

(iv) monitoring the current inhalation window for the patient and determining a filtered resting inhalation window specific to the patient,

(v) calculating a new resting inhalation window by combining the current resting inhalation window and the current inhalation window with an algorithm and weighting them respectively to provide the resting inhalation window;

(b) determining a flow of the dose of the gaseous drug based on a duration of the inhalation window; and

(c) delivering the dose of the gaseous drug within a second inhalation window at the lowest flow.

13. The method as recited in claim 12 wherein the dose is delivered during a first two-thirds of the second inhalation cycle.

14. The method as recited in claim 12 wherein the dose and flow are provided by the control circuit choosing from a low flow valve, a high flow valve, a combination of the low flow and high flow valves or a continuous flow switch.

15. A dosing apparatus for providing a dose of a gaseous drug to a patient that has a respiratory disorder comprising:

(a) a control circuit; including a vacuum sensor, a microprocessor, an algorithm, and an internal clock that determines a normal resting breath rate for the patient by:

(i) sensing transitions between patient inhalations and exhalations,

(ii) monitoring and tracking the transitions,

(iii) calculating the current breath rate of the patient,

(iv) monitoring the current breath rate and determining a filtered normal resting rate specific to the patient by excluding her breath rates, and

(v) calculating a new normal resting breath rate by combining the current normal resting breath rate and the current breath rate with the algorithm and weighting them respectively to provide a new normal resting breath rate;

(b) a vacuum pressure sensor that is connected to a patient to sense patient inhalation and transmits the patient inhalation information to the control circuit;

(c) a connection port for connection to a gaseous drug supply;

(d) a gaseous drug delivery device that allows the volume of the gaseous drug delivered to the patient to be varied; and

(e) a power supply that provides power to the apparatus.

16. The apparatus as recited in claim 15 wherein the gaseous drug delivery device comprises:

(a) a low flow valve controlled by the control circuit; and

(b) a high flow valve controlled by the control circuit.

17. The apparatus as recited in claim 15 including a continuous flow valve controlled by the control circuit.

18. The apparatus as recited in claim 15 wherein the gaseous drug delivery device comprises a variable flow valve.

19. The apparatus as recited in claim 15 wherein the gaseous drug supply is a liquid oxygen reservoir.

Assignments (22)
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (041458/0927) Recorded Nov 9, 2025
From: BARCLAYS BANK PLC
To: MEDICAL DEPOT, INC.
Reel/Frame 073512/0360 →
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (041455/0589) Recorded Nov 9, 2025
From: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
To: MEDICAL DEPOT, INC.
Reel/Frame 073512/0410 →
SECURITY INTEREST Recorded Nov 3, 2025
From: DEVILBISS HEALTHCARE LLC; HURRYWORKS LLC; INOVO, INC.; MEDICAL DEPOT, INC.; DRIVE MEDICAL CANADA INC.
To: FORTRESS CREDIT CORP., AS COLLATERAL AGENT
Reel/Frame 073529/0050 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jul 27, 2021
From: DELAWARE TRUST COMPANY
To: MEDICAL DEPOT, INC.
Reel/Frame 056990/0271 →
SECURITY INTEREST Recorded Oct 4, 2019
From: MEDICAL DEPOT, INC.
To: DELAWARE TRUST COMPANY, AS COLLATERAL AGENT
Reel/Frame 050628/0436 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS - SECOND LIEN Recorded Jan 20, 2017
From: MEDICAL DEPOT, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 041458/0927 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS - FIRST LIEN Recorded Jan 20, 2017
From: MEDICAL DEPOT, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 041455/0589 →
RELEASE OF SECURITY INTEREST Recorded Jan 3, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC
To: MEDICAL DEPOT, INC.
Reel/Frame 040832/0544 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 18, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037145/0518 →
SECURITY AGREEMENT Recorded Sep 27, 2013
From: MEDICAL DEPOT, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 031307/0117 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2012
From: GLOBAL MEDICAL HOLDINGS LLC
To: MEDICAL DEPOT, INC.
Reel/Frame 029055/0094 →
RELEASE OF SECURITY INTEREST Recorded Oct 1, 2012
From: SILICON VALLEY BANK
To: INSPIRED TECHNOLOGIES, INC.
Reel/Frame 029053/0548 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT AND CHANGE IT TO A NUNC PRO TUNC ASSIGNMENT, WITH AN EFFECTIVE DATE OF OCTOBER 31, 2011. PREVIOUSLY RECORDED ON REEL 027528 FRAME 0229. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT FROM SWYNSON LIMITED AND MICHAEL J. HUNT TO GLOBAL MEDICAL HOLDINGS LLC. Recorded Jul 27, 2012
From: SWYNSON LIMITED; HUNT, MICHAEL J.
To: GLOBAL MEDICAL HOLDINGS LLC
Reel/Frame 028655/0285 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT AND CHANGE IT TO A NUNC PRO TUNC ASSIGNMENT, WITH AN EFFECTIVE DATE OF DECEMBER 22, 2010. PREVIOUSLY RECORDED ON REEL 027527 FRAME 0818. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT FROM INSPIRED TECHNOLOGIES, INC. TO MEDICAL INDUSTRIES OF AMERICA, INC., DBA EVO MEDICAL SOLUTIONS. Recorded Jul 27, 2012
From: INSPIRED TECHNOLOGIES, INC.
To: MEDICAL INDUSTRIES OF AMERICA, INC., DBA EVO MEDICAL SOLUTIONS
Reel/Frame 028655/0150 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT AND CHANGED IT TO A NUNC PRO TUNC ASSIGNMENT, WITH AN EFFECTIVE DATE OF OCTOBER 6, 2011. PREVIOUSLY RECORDED ON REEL 027532 FRAME 0166. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT FROM MEDICAL INDUSTRIES OF AMERICA, INC., DBA EVO MEDICAL SOLUTIONS TO SWYNSON LIMITED AND MICHAEL J. HUNT. Recorded Jul 27, 2012
From: MEDICAL INDUSTRIES OF AMERICA, INC., DBA EVO MEDICAL SOLUTIONS
To: SWYNSON LIMITED; HUNT, MICHAEL J.
Reel/Frame 028655/0297 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2012
From: MEDICAL INDUSTRIES OF AMERICA, INC., DBA EVO MEDICAL SOLUTIONS
To: SWYNSON LIMITED; HUNT, MICHAEL J.
Reel/Frame 027532/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2012
From: INSPIRED TECHNOLOGIES, INC.
To: MEDICAL INDUSTRIES OF AMERICA, INC., DBA EVO MEDICAL SOLUTIONS
Reel/Frame 027527/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2012
From: SWYNSON LIMITED; HUNT, MICHAEL J.
To: GLOBAL MEDICAL HOLDINGS LLC
Reel/Frame 027528/0229 →
SECURITY AGREEMENT Recorded Feb 24, 2009
From: INSPIRED TECHNOLOGIES, INC.
To: SILICON VALLEY BANK
Reel/Frame 022305/0487 →
CHANGE OF NAME Recorded Feb 17, 2009
From: COPD PARTNERS, INC.
To: INSPIRED TECHNOLOGIES, INC.
Reel/Frame 022274/0095 →
SECURITY AGREEMENT Recorded Oct 3, 2007
From: SRI ACQUISITION CORP.
To: ORIX VENTURE FINANCE, LLC
Reel/Frame 019914/0375 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2007
From: EASLEY, DAN; DIRKS, AARON; MCCOY, ROBERT
To: COPD PARTNERS, INC.
Reel/Frame 019249/0696 →